Identifying ESR1 Mutations to Determine Resistance in HR+ Metastatic Breast Cancer
Cancer Therapy Advisor,
By Clinical Content Hub The global disease burden of breast cancer (BC) is a serious health concern worldwide, especially among…
By Clinical Content Hub The global disease burden of breast cancer (BC) is a serious health concern worldwide, especially among…
The combination of alpelisib plus endocrine therapy elicited a clinical benefit across all subgroups of patients with hormone…
The thresholds for genomic instability scores in triple-negative breast cancer (TNBC) are similar to those in ovarian cancer…
The strategy of simultaneously exploiting deficient DNA damage repair and unleashing the immune response could expand treatment…
Advertisement The data made available by TCGA represent fantastic opportunities for exploration and deeper understanding of the…
Action Points Note that this observational study identified genes that are preferentially mutated in invasive lobular breast…
As thousands of Canadians walk and run to raise funds for breast cancer research this weekend, the reality is that much of the…
Data may help improve treatment
Manchmal kann eine Anti-Hormon-Therapie helfen, manchmal spezielle Antikörper - und in anderen Fällen nutzt keines von beiden.
( NIH/National Cancer Institute ) One subtype of breast cancer shares many genetic features with high-grade serous ovarian…